Can We Target the Microbiome to Improve Outcomes in Osteoarthritis and Arthroplasty?
The Journal of Arthroplasty · 2026-11
DOI: 10.1016/j.arth.2026.10.044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Arthroplasty, 2026-11. Verfasst von Ghazal Pourbozorg und 4 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Center, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey; Fellow, International Consensus Meeting (ICM), Department of O…. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
Osteoarthritis (OA) is the most prevalent degenerative joint disease and a leading cause of pain, disability, and joint arthroplasty worldwide. Despite advances in surgical technique and perioperative care, periprosthetic joint infection (PJI) remains a devastating complication associated with substantial morbidity, mortality, and healthcare costs. Increasing evidence suggests that the gut microbiome plays a central role in regulating systemic inflammation, immune competence, metabolic homeostasis, and intestinal barrier integrity, biological processes relevant to both OA progression and postoperative infection risk. Preclinical and emerging clinical studies support the existence of a gut-joint axis, whereby alterations in gut microbial composition and microbial metabolites, such as short-chain fatty acids (SCFAs), bile acids, lipopolysaccharides, tryptophan-derived metabolites, and other immunomodulatory compounds, influence joint inflammation, cartilage degeneration, and host immune responses. Experimental models demonstrate that dysbiosis exacerbates OA-related joint damage, while targeted modulation of the gut microbiome can attenuate inflammation, reduce oxidative stress, and preserve cartilage integrity. Importantly, perioperative factors such as surgical stress, antibiotic exposure, and nutritional changes may further disrupt gut microbial homeostasis, potentially impairing immune resilience and increasing susceptibility to PJI. Microbiome-targeted strategies, including dietary modification, probiotics, prebiotics, and physical activity, have shown promise in restoring microbial balance and supporting immune regulation in arthritic populations. Although most evidence remains preclinical or observational, these findings suggest that modulation of the gut microbiome represents a biologically plausible adjunctive approach for both osteoarthritis management and perioperative optimization. This review summarizes current evidence linking the gut microbiome to OA pathophysiology and surgical outcomes and evaluates the potential role of microbiome modulation in joint health optimization and PJI risk reduction. Although biologically compelling, current evidence remains largely preclinical and observational, and prospective clinical trials are required before routine implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Joint Center, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey; Fellow, International Consensus Meeting (ICM), Department of Orthopedics and Trauma Surgery, University Medical Center Schleswig-Hol…
- Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, CA, USA; Department of Orthopaedic Surgery, Keck Medical Center of USC, 1520 San Pablo St, Ste 2000, Los Angeles, CA, 90033, USA.
- LifeBridge Health, Sinai Hospital of Baltimore, The Rubin Institute for Advanced Orthopedics, Baltimore, Maryland.
- International Joint Center, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey. Electronic address: javadparvizi@gmail.com.
Zitieren
APA
Pourbozorg, G., Heckmann, N. D., Mont, M. A., Lieberman, J. R., & Parvizi, J. (2026). Can We Target the Microbiome to Improve Outcomes in Osteoarthritis and Arthroplasty?. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2026.10.044
Vancouver
Pourbozorg G, Heckmann ND, Mont MA, Lieberman JR, Parvizi J. Can We Target the Microbiome to Improve Outcomes in Osteoarthritis and Arthroplasty?. The Journal of Arthroplasty. 2026. doi:10.1016/j.arth.2026.10.044
BibTeX
@article{Pourbozorg2026,
author = {Pourbozorg, Ghazal and Heckmann, Nathanael D and Mont, Michael A and Lieberman, Jay R and Parvizi, Javad},
title = {Can We Target the Microbiome to Improve Outcomes in Osteoarthritis and Arthroplasty?},
journal = {The Journal of Arthroplasty},
year = {2026},
doi = {10.1016/j.arth.2026.10.044}
}
EUVIMED